scispace - formally typeset
Open AccessJournal Article

Adaptive Immune Features of Natural Killer Cells

Reads0
Chats0
TLDR
In this paper, the authors used a mouse model of cytomegalovirus infection to show that, like T cells, NK cells bearing the virus-specific Ly49H receptor proliferate 100fold in the spleen and 1,000-fold in liver after infection.
Abstract
In an adaptive immune response, naive T cells proliferate during infection and generate long-lived memory cells that undergo secondary expansion after a repeat encounter with the same pathogen. Although natural killer (NK) cells have traditionally been classified as cells of the innate immune system, they share many similarities with cytotoxic T lymphocytes. We use a mouse model of cytomegalovirus infection to show that, like T cells, NK cells bearing the virus-specific Ly49H receptor proliferate 100-fold in the spleen and 1,000-fold in the liver after infection. After a contraction phase, Ly49H-positive NK cells reside in lymphoid and non-lymphoid organs for several months. These self-renewing 'memory' NK cells rapidly degranulate and produce cytokines on reactivation. Adoptive transfer of these NK cells into naive animals followed by viral challenge results in a robust secondary expansion and protective immunity. These findings reveal properties of NK cells that were previously attributed only to cells of the adaptive immune system.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Natural killer cells in antitumour adoptive cell immunotherapy

TL;DR: In this article , the authors describe various approaches to augment NK cell cytotoxicity and longevity, evaluate challenges and opportunities, and reflect on how lessons learned from the clinic will guide the design of next-generation NK cell products that will address the unique complexities of each cancer.
Journal ArticleDOI

Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

TL;DR: The key features that underlie why NK cells are emerging as important new additions to the cancer therapeutic arsenal are considered.
Journal ArticleDOI

Trained ILC3 responses promote intestinal defense

TL;DR: Intestinal group 3 innate lymphoid cells have memory-like properties after bacterial infection that contribute to long-term mucosal defense, and these “trained” ILC3s (Tr-ILC3s) showed superior activation and controlled infection better than “naïve’ I LC3s after pathogen rechallenge.
Journal ArticleDOI

Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy

TL;DR: P phenotypic diversities of TILs and their connections with prognosis in CRC are summarized and insights into the subsets-specific nature of Tils with different MSI status are provided.
Journal ArticleDOI

Inflammatory memory and tissue adaptation in sickness and in health

Shruti Naik, +1 more
- 01 Jul 2022 - 
TL;DR: A review on inflammatory memory in non-immune cells of different epithelia and neurons, and the potential mechanisms controlling these epigenetic memories and their implications in human health and disease is presented in this article .
References
More filters
Journal ArticleDOI

Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?

TL;DR: New findings showing how NK cells possess nearly all of the features of adaptive immunity including memory are proposed, proposing the placement of NK cells as an “evolutionary bridge” between innate and adaptive immunity.
Journal ArticleDOI

Current progress in development of hepatitis C virus vaccines

TL;DR: Advances in the understanding of virus-host interactions and protective immunity in hepatitis C virus infection provide an important roadmap to develop potent and broadly directed vaccine candidates targeting both humoral and cellular immune responses.
Journal ArticleDOI

Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype: An Adaptive Component of Nk Cell–Mediated Responses

TL;DR: It is shown here that infiltration of activated NK cells into the peritoneal cavity in response to tumor cells is controlled by the tumor major histocompatibility complex (MHC) class I phenotype.
Journal ArticleDOI

Clinical utility of natural killer cells in cancer therapy and transplantation

TL;DR: Future strategies include exploiting favorable donor immunogenetics or ex vivo expansion of NK cells from blood, progenitors, or pluripotent cells, and monoclonal antibodies and bispecific killer engagers (BiKEs) may enhance specificity by targeting CD16 on NK cells to tumor antigens.
Related Papers (5)